An exploratory study of the consistency of balance control and the mobility of people with Parkinson's Disease (PD) between medication doses
An exploratory study of the consistency of balance control and the mobility of people with Parkinson's Disease (PD) between medication doses
Objective: To evaluate the consistency of balance control, mobility and perceived difficulties with functional tasks by people on carefully controlled anti-parkinsonian medication programmes, between doses on a single day and across days using standard clinical measures.
Design: Small group prospective study.
Setting: A hospital outpatient physiotherapy department.
Subjects: Subjects, recruited from a specialist Parkinson's disease (PD) clinic, had to be independently mobile, diagnosed with PD at least five years previously and on a stable drug regime.
Method: Assessments (timed up and go, functional reach and a tap test) were completed 30 minutes prior to medication and hourly for 4 hours. They were repeated on a second day within a seven-day period. The self-assessment of functional disability was completed during the worst and best periods of the drug cycle. A general linear model (repeated measures analysis of variance) was used to analyse the data.
Results: Nine subjects (8 males) with PD (grade III Hoehn and Yahr, average duration of symptoms eight years), average age 72 years, were recruited to the study. Four subjects had worse Hoehn and Yahr scores (grade 4) during the worst phase of the L-dopa cycle. Balance and mobility data did not change significantly over the medication cycle. Tests on day 2 were similar to day 1 with only the tap test showing a significant mean difference (p = 0.02) (2.6, 95% confidence interval (CI) 0.5-4.8). Individuals perceived significantly greater difficulty (mean difference = 7.9, 95% CI 3.6-12.2) (p < 0.001) in achieving functional tasks at the end of dose than peak dose of the medication cycle.
Conclusion: Measures of balance and mobility remained stable over the cycle. Fluctuations in the perception of difficulties with daily functional tasks were not accompanied by observed fluctuations in performance. The improvement in the mean of the tap test over the days could reflect a learning effect.
disease
318 - 324
Campbell, F.
a0f36565-1a39-4aeb-8e77-54c7134f2b19
Ashburn, A.
ceaa5f52-a1c3-45a8-b175-5ac690c25780
Thomas, P.
260a29e1-369d-4578-a3df-0e3ba5346608
Amar, K.
9b704f6d-9c4b-4502-8769-6fe134b5b9fb
2002
Campbell, F.
a0f36565-1a39-4aeb-8e77-54c7134f2b19
Ashburn, A.
ceaa5f52-a1c3-45a8-b175-5ac690c25780
Thomas, P.
260a29e1-369d-4578-a3df-0e3ba5346608
Amar, K.
9b704f6d-9c4b-4502-8769-6fe134b5b9fb
Campbell, F., Ashburn, A., Thomas, P. and Amar, K.
(2002)
An exploratory study of the consistency of balance control and the mobility of people with Parkinson's Disease (PD) between medication doses.
Clinical Rehabilitation, 17 (3), .
(doi:10.1191/0269215503cr614oa).
Abstract
Objective: To evaluate the consistency of balance control, mobility and perceived difficulties with functional tasks by people on carefully controlled anti-parkinsonian medication programmes, between doses on a single day and across days using standard clinical measures.
Design: Small group prospective study.
Setting: A hospital outpatient physiotherapy department.
Subjects: Subjects, recruited from a specialist Parkinson's disease (PD) clinic, had to be independently mobile, diagnosed with PD at least five years previously and on a stable drug regime.
Method: Assessments (timed up and go, functional reach and a tap test) were completed 30 minutes prior to medication and hourly for 4 hours. They were repeated on a second day within a seven-day period. The self-assessment of functional disability was completed during the worst and best periods of the drug cycle. A general linear model (repeated measures analysis of variance) was used to analyse the data.
Results: Nine subjects (8 males) with PD (grade III Hoehn and Yahr, average duration of symptoms eight years), average age 72 years, were recruited to the study. Four subjects had worse Hoehn and Yahr scores (grade 4) during the worst phase of the L-dopa cycle. Balance and mobility data did not change significantly over the medication cycle. Tests on day 2 were similar to day 1 with only the tap test showing a significant mean difference (p = 0.02) (2.6, 95% confidence interval (CI) 0.5-4.8). Individuals perceived significantly greater difficulty (mean difference = 7.9, 95% CI 3.6-12.2) (p < 0.001) in achieving functional tasks at the end of dose than peak dose of the medication cycle.
Conclusion: Measures of balance and mobility remained stable over the cycle. Fluctuations in the perception of difficulties with daily functional tasks were not accompanied by observed fluctuations in performance. The improvement in the mean of the tap test over the days could reflect a learning effect.
This record has no associated files available for download.
More information
Published date: 2002
Keywords:
disease
Identifiers
Local EPrints ID: 17847
URI: http://eprints.soton.ac.uk/id/eprint/17847
ISSN: 0269-2155
PURE UUID: 92865391-0e14-4744-b477-aeca4e76213a
Catalogue record
Date deposited: 27 Oct 2005
Last modified: 15 Mar 2024 06:01
Export record
Altmetrics
Contributors
Author:
F. Campbell
Author:
A. Ashburn
Author:
P. Thomas
Author:
K. Amar
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics